ow-density electroencephalography for the assessment and post-treatment evaluation of absence epilepsy seizures

ancaster University0 sites2 target enrollmentMay 10, 2018

Overview

No summary available.

Registry

who.int

Start Date

May 10, 2018

End Date

September 30, 2019

Last Updated

6 years ago

Study Type

Interventional

Sex

All

Sponsor

ancaster University

•1\. Subjects eligible for inclusion in the experimental group for this study are children suspected of having absence seizures between the ages of 3\- to 12\-years
•2\. Subjects eligible for inclusion into the clinical control group are patients of a similar age, referred to Preston for a routine EEG, but not suspected of having absence seizures. If a patient is initially included in the experimental group but gets diagnosed with another condition other than absence seizures, they will be placed in the clinical control group
•3\. A further non\-clinical control group, also age matched, will be collected at Lancaster University

•1\. Confounding medication use:
•1\.1\. Ritalin
•1\.2\. Antidepressants
•1\.3\. Neuroleptic medications
•1\.4\. Anti\-epileptics
•2\. Significant learning difficulties, e.g. autism
•3\. Neurological conditions, e.g. cerebral palsy
•4\. The CI may judge a participant unable to take part in the non\-clinical control group if they have a diagnosis of any neurological disorders